semaglutide off the market India's obesity and diabetes drug is on verge of taking off. Semaglutide, the molecule behind Ozempic and Wegovy will go patent this Saturday paving the way for low-cost generic drugs Semaglutide shortage ends as FDA

Medical Detox Fat cells hold on to toxins that can prevent weight loss

Europe Market Split by Country The GLP-1 diabetes treatment drugs market in Europe is projected to grow from USD 1,708.0 million in 2025 to USD 14,836.7 million by 2035, registering a CAGR of 23.3% over the forecast period

Spread high-fiber foods across the day rather than concentrating them in one meal

Compounded semaglutide is prepared by a licensed pharmacy based on an individual prescription, without FDA premarket review of the finished preparation

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses